Alexion Spikes As Company Hires Goldman Sachs (ALXN)
Shares of Alexion jumped as high as $120.48, or 10.2 percent on the news. More than 2.5 million shares have already been traded, compared to the average of 2.03 million.
A previous offer from Roche was rejected, but Alexion will be working with Goldman Sachs in the case that Roche raises their offer to a level the pharmaceutical company finds appealing.
Bloomberg reported that Roche is interested in both the company’s blood medication and pipeline.
Analysts will likely review the company in the near future.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.